{"url_path":"/sec/derm/8-k/2026-05-13/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1867066/0001104659-26-060232-index.html","accession_number":"0001104659-26-060232","cik":"0001867066","ticker":"DERM","issuer_name":"Journey Medical Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1867066/0001104659-26-060232-index.html","primary_entity_key":"0001867066","primary_entity_name":"Journey Medical Corp"},"word_count":94,"has_tables":true,"body_markdown":"** **\n\n**Item 9.01.**\n**Financial Statements and Exhibits.**\n\n \n\n(d) Exhibits.\n\n \n\nThe following exhibits are furnished herewith:\n\n \n\n**Exhibit\nNumber**\n \n**Description**\n\n[99.1](tm2614268d1_ex99-1.htm)\n \n[Press release issued by Journey Medical Corporation, dated May 13, 2026.](tm2614268d1_ex99-1.htm)\n\n104\n \nCover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL).\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements\nof the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto\nduly authorized.\n\n \n\n \n**Journey Medical Corporation**\n\n \n(Registrant)\n\n \n \n\n \nBy:\n/s/ Claude Maraoui\n\n \n \nClaude Maraoui\n\n \n \nChief Executive Officer, President and Director\n\n \n\nDate: May 13, 2026"}